NCT06255925 A Strength-Based Employment Maintenance Program for Individuals on the Autism Spectrum
| NCT ID | NCT06255925 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kessler Foundation |
| Condition | Autism |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-01-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are looking to evaluate how effective a training program that focuses on character strengths may be in improving job maintenance skills in young adults. The investigators are examining the effects of this intervention in young adults who feel they would like to help in improving their satisfaction with work, and in keeping their jobs.
Eligibility Criteria
Inclusion Criteria: * Lives in the United States of America * Between the ages of 14-26 * Speaks English well and at a 4th grade reading level Exclusion Criteria: * Had a stroke, Traumatic Brain Injury, or neurological injury or disease in the past(like brain tumor or epilepsy) * Has a history of significant psychiatric illness(like schizophrenia or psychosis) * Has uncontrolled seizures or other unstable medical complications
Contact & Investigator
Helen Genova, Ph. D.
PRINCIPAL INVESTIGATOR
Kessler Foundation
Frequently Asked Questions
Who can join the NCT06255925 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 26 Years, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06255925 currently recruiting?
Yes, NCT06255925 is actively recruiting participants. Contact the research team at hgenova@kesslerfoundation.org for enrollment information.
Where is the NCT06255925 trial being conducted?
This trial is being conducted at East Hanover, United States.
Who is sponsoring the NCT06255925 clinical trial?
NCT06255925 is sponsored by Kessler Foundation. The principal investigator is Helen Genova, Ph. D. at Kessler Foundation. The trial plans to enroll 30 participants.